Exploring the complexity of cardiometabolic risk in women

Biological Research for Nursing

Volumn 14, Issue 2, 2012, Pages 160-170

  Robins, Jo Lynne W ^a   McCain, Nancy L ^a   Elswick, R K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

cardiometabolic risk; cardiovascular disease; women's health

Indexed keywords

EID: 84860137547     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800411398652     Document Type: Article

References (78)

1. Adachi R.,Honma Y.,Masuno H.,Kawana K.,Shimomura I.,Yamada S.,Makishima M.Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative.Journal of Lipid Research. 2005;46:46-57.
2. Adam T.,Epel E.Stress, eating and the reward system.Physiology and Behavior. 2007;91:449-458.
3. Alberti K. G.,Eckel R. H.,Grundy S. M.,Zimmet P. Z.,Cleeman J. I.,Donato Smith, S. C.Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.Circulation. 2009;120:1640-1645.
4. Alexandraki K.,Piperi C.,Kalofoutis C.,Singh J.,Alaveras A.,Kalofoutis A.Inflammatory process in type 2 diabetes: The role of cytokines.Annals of the New York Academy of Sciences. 2006;1084:89-117.
5. American Heart Association. (2010). Women and cardiovascular disease-statistics. Retrieved May 7, 2010, fromhttp://www.americanheart.org/presenter.jhtml.
6. Anda R.,Williamson D.,Jones D.,Macera C.,Eaker E.,Glassman A.,Marks J.Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults.Epidemiology. 1993;4:285-294.
7. Appels A.,Mulder P.Excess fatigue as a precursor to myocardial infarction.European Heart Journal. 1988;9:758-764.
8. Baldini V.,Mastropasqua M.,Francucci C. M.,D'Erasmo E.Cardiovascular disease and osteoporosis.Journal of Endocrinological Investigation. 2005;28:69-72.
9. Bastard J.,Maachi M.,Lagathu C.,Kim M.,Caron M.,Vidal H., Feve B.Recent advances in the relationship between obesity, inflammation, and insulin resistance.European Cytokine Network. 2006;17:4-12.
10. Bedinghaus J.,Leshan L.,Diehr S.Coronary artery disease prevention: What's different for women?.American Family Physician. 2001;63:1393-1396.
11. Behre C. J.,Fagerberg B.,Hulten L. M.,Hulthe J.The reciprocal association of adipocytokines with insulin resistance and C-reactive protein in clinically healthy men.Metabolism. 2005;54:439-444.
12. Beltowski J.Adiponectin and resistin-new hormones of white adipose tissue.Medical Science Monitor. 2003;9:RA55-RA61.
13. Bland S. H.,Krogh V.,Winkelstein W.,Trevisan M.Social network and blood pressure: A population study.Psychosomatic Medicine. 1991;53:598-607.
14. Canaris G. J.,Manowitz N. R.,Mayor G.,Ridgway E. C.The Colorado Thyroid Disease Prevalence Study.Archives of Internal Medicine. 2000;160:526-534.
15. Chen H.,Montagnani M.,Funahashi T.,Shimomura I.,Quon M. J.Adiponectin stimulates production of nitric oxide in vascular endothelial cells.Journal of Biological Chemistry. 2003;278:45021-45026.
16. Cohen S.,Karmarck T.,Mermelstein R.A global measure of perceived stress.Journal of Health and Social Behavior. 1983;24:385-396.
17. Dantzer R.,O'Connor J. C.,Freund G. G.,Johnson R. W.,Kelley K. W.From inflammation to sickness and depression: When the immune system subjugates the brain.Nature Reviews: Neuroscience. 2008;9:46-57.
18. Diamantopoulos E. J.,Andreadis E. A.,Tsourous G. I.,Katsanou P. M.,Georgiopoulos D. X.,Dimitriadis G. D.,Raptis S. A.Intermediate post-challenge hyperglycemia in overweight and obese subjects: A new marker of impaired glucose regulation?.Angiology. 2006;57:709-716.
19. Duplessis C.,Rascona D.,Cullum M.,Yeung E.Salivary and free serum cortisol evaluation.Military Medicine. 2010;175:340-346.
20. Empana J.Adiponectin isoforms and cardiovascular disease: The epidemiological evidence has just begun.European Heart Journal. 2008;29:1307-1315.
21. Folkman S.Positive psychological states and coping with severe stress.Social Science & Medicine. 1997;45:1207-1221.
22. Frasure-Smith N.,Lesperance F.Recent evidence linking coronary heart disease and depression.Canadian Journal of Psychiatry. 2006;51:730-737.
23. Gozansky W. S.,Lynn J. S.,Laudenslager M. L.,Kohrt W. M.Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic-pituitary-adrenal activity.Clinical Endocrinology. 2005;63:336-341.
24. Guest C. B.,Yan G.,O'Connor J.,Freund G. G.Psychoneuroimmunology. 2007). Obesity and immunity. In AderR. (Ed.), Psychoneuroimmunology. (pp. 993-1011). (4th ed.(. New York, NY: Elsevier.Ader R., ed. New York, NY: Elsevier; 2007:993-1011.
25. Haffner S. M.Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.Obesity. 2006;14:121S-127S.
26. Haffner S. M.Managing cardiometabolic risk: Do we have all the answers?.Canadian Journal of Medicine. 2007;120:S10-S16.
27. Hatch R. L.,Burg M. A.,Naberhaus D. S.,Hellmich L. K.The Spiritual Involvement and Beliefs Scale: Development and testing of a new instrument.Journal of Family Practice. 1998;46:476-486.
28. Heine R. J.,Balkau B.,Ceriello A.,Del P. S.,Horton E. S.,Taskinen M. R.What does postprandial hyperglycaemia mean?.Diabetic Medicine. 2004;21:208-213.
29. Heitman L. K.The influence of social support on cardiovascular health in families.Family and Community Health. 2006;29:131-142.
30. Holick M. F.Vitamin D: Important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers.Southern Medical Journal. 2005;98:1024-1027.
31. Holmes S. D.,Krantz D. S.,Rogers H.,Gottdiener J.,Contrada R. J.Mental stress and coronary artery disease: A multidisciplinary guide.Progress in Cardiovascular Diseases. 2006;49:106-122.
32. Howard B. V.,Campbell L.,Allen C.,Black H.,Passaro M.,Rodabough R. J., Wagenknecht L. E.Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups.International Journal of Obesity Related Metabolic Disorders. 2004;28:1039-1047.
33. Hu F.,Manson J.,Stampfer M.,Colditz G.,Liu S.,Solomon C.,Willett W.Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.New England Journal of Medicine. 2001;345:790-797.
34. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. (2004). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure(NIH Publication No. 04-5230). Retrieved from the National Heart, Blood, and Lung Institute, National Institutes of Health website: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm.
35. Jones D. S.,Bland J. S.,Quinn S.Textbook of functional medicine. Jones D., ed. Gig Harbor, WA: Institute for Functional Medicine; 2005:5-14.
36. Krantz D. S.,Manuck S. B.Acute psychophysiologic reactivity and risk of cardiovascular disease: A review and methodologic critique.Psychological Bulletin. 1984;96:435-464.
37. Krantz D. S.,McCeney M. K.Effects of psychological and social factors on organic disease: A critical assessment of research on coronary heart disease.Annual Review of Psychology. 2002;53:341-369.
38. Lepore S. J.Problems and prospects for the social support-reactivity hypothesis.Annals of Behavioral Medicine. 1998;20:257-269.
39. Lowe B.,Hochlehnert A.,Nikendei C.Metabolic syndrome and depression.Therapeutische Umschau. 2006;63:521-527.
40. Lundberg U.,Frankenhaeuser M.Stress and workload of men and women in high-ranking positions.Journal of Occupational Health Psychology. 1999;4:142-151.
41. Martini L. A.,Wood R. J.Vitamin D status and the metabolic syndrome.Nutrition Reviews. 2006;64:479-486.
42. Massoudi M. S.,Meilahn E. N.,Orchard T. J.,Foley T. P,Kuller L. H.,Costantino J. P.,Buhari A. M.Prevalence of thyroid antibodies among healthy middle-aged women. Findings from the thyroid study in healthy women.Annals of Epidemiology. 1995;5:229-233.
43. Matsuzawa Y.,Funahashi T.,Kihara S.,Shimomura I.Adiponectin and metabolic syndrome.Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:29-33.
44. McDade T. W.,Hawkley L. C.,Cacioppo J. T.Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: The Chicago Health, Aging, and Social Relations Study.Psychosomatic Medicine. 2006;68:376-381.
45. McEwen B. S.Protective and damaging effects of stress mediators.Annals of the New York Academy of Sciences. 1998;840:33-44.
46. Mosca L.,Banka C. L.,Benjamin E. J.,Berra K.,Bushnell C.,Dolor R. J., Wenger N. K.Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.Circulation. 2007;115:1481-1501.
47. Moyer A. E.,Rodin J.,Grilo C. M.,Cummings N.,Larson L. M.,Rebuffe-Scrive M.Stress induced cortisol response and fat distribution in women.Obesity Research. 1994;2:255-262.
48. Neu M.,Goldstein M.,Gao D.,Laudenslager M. L.Salivary cortisol in preterm infants: Validation of a simple method for collecting saliva for cortisol determination.Early Human Development. 2007;83:47-54.
49. Okamoto Y.,Kihara S.,Funahashi T.,Matsuzawa Y.,Libby P.Adiponectin: A key adipocytokine in metabolic syndrome.Clinical Science. 2006;110:267-278.
50. Olszanecka-Glinianowicz M.,Zahorska-Markiewicz B.,Janowska J.The effect of weight loss on serum concentrations of nitric oxide, TNF-alpha and soluble TNF-alpha receptors.Endokrynologia Polska. 2006;57:487-493.
51. Pajvani U. B.,Hawkins M.,Combs T. P.,Rajala M. W.,Doebber T.,Berger J. P., Scherer P. E.Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.Journal of Biological Chemistry. 2004;279:12152-12162.
52. Pickup J. C.Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.Diabetes Care. 2004;27:813-823.
53. Pi-Sunyer F. X.The relation of adipose tissue to cardiometabolic risk.Clinical Cornerstone. 2006;8:S14-S23.
54. Powell L. H.,Shahabi L.,Thoresen C. E.Religion and spirituality: Linkages to physical health.American Psychologist. 2003;58:36-52.
55. Radloff L. S.The CES-D Scale: A self-report depression scale for research in the general population.Applied Psychological Measures. 1977;1:385-401.
56. Rana T.,Li Y.,Manson J. E.,Hu F. B.Adiposity compared with physical inactivity and risk of type 2 diabetes in women.Diabetes Care. 2007;30:53-58.
57. Rasmusson A. M.,Vasek J.,Lipschitz D. S.,Vojvoda D.,Mustone M. E.,Shi Q., Charney D. S.An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood symptoms in women with PTSD.Neuropsychopharmacology. 2004;29:1546-1557.
58. Rasouli M.,Kiasari A. M.Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.Clinical Biochemistry. 2006;39:971-977.
59. Reed P. G.Religiousness among terminally ill and healthy adults.Research in Nursing and Health. 1986;9:35-42.
60. Reed P. G.Spirituality and well-being in terminally ill hospitalized adults.Research in Nursing and Health. 1987;10:335-344.
61. Ritchie S. A.,Connell J. M.The link between abdominal obesity, metabolic syndrome and cardiovascular disease.Nutrition, Metabolism, and Cardiovascular Disease. 2006;17:319-326.
62. Roos A.,Baker S.,Links T.,Gans R.,Wolffenbuttel B.Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.Journal of Clinical Endocrinology and Metabolism. 2007;92:491-496.
63. Rueda B.,Perez-Garcia A. M.Gender and social support in the context of cardiovascular disease.Women & Health. 2006;43:59-73.
64. Sanchez-Munoz F.,Garcia-Macedo R.,Alcon-Aguilar F.,Cruz M.Adipocytokines, adipose tissue and its relationship with immune system cells.Gaceta médica de Mexico. 2005;141:505-512.
65. Schleithoff S. S.,Zittermann A.,Tenderich G.,Berthold H. K.,Stehle P.,Koerfer R.Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial.American Journal of Clinical Nutrition. 2006;83:754-759.
66. Seeman T. E.,McEwen B. S.Impact of social environment characteristics on neuroendocrine regulation.Psychosomatic Medicine. 1996;58:459-471.
67. Stumvoll M.,Mitrakou A.,Pimenta W.,Jenssen T.,Yki-Jarvinen H.,VanHaeften T., Gerich J.Use of oral glucose tolerance test to assess insulin release and insulin sensitivity.Diabetes Care. 2000;23:295-301.
68. Tilg H.,Moschen A. R.Role of adiponectin and PBEF/visfatin as regulators of inflammation: Involvement in obesity-associated diseases.Clinical Science. 2008;114:275-288.
69. Tomizawa A.,Hattori Y.,Kasai K.,Nakano Y.Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelial cells: Globular adiponectin vs. high molecular weight adiponectin.Diabetes and Vascular Disease Research. 2008;5:123-127.
70. Trigo M.,Silva D.,Rocha E.Psychosocial risk factors in coronary heart disease: Beyond type A behavior.Revista Portuguesa de Cardiologia. 2005;24:261-281.
71. Van der Kooy K.,van Hout H.,Marwijk H.,Marten H.,Stehouwer C.,Beekman A.Depression and the risk for cardiovascular diseases: Systematic review and metaanalysis.International Journal of Geriatric Psychiatry. 2007;22:613-626.
72. Vanitallie T. B.Stress: A risk factor for serious illness.Metabolism. 2002;6:40-45.
73. Vieth R.,Kimball S.Vitamin D in congestive heart failure.American Journal of Clinical Nutrition. 2006;83:731-732.
74. Vogt T. M.,Mullooly J. P.,Ernst D.,Pope C. R.,Hollis J. F.Social networks as predictors of ischemic heart disease, cancer, stroke and hypertension: Incidence, survival and mortality.Journal of Clinical Epidemiology. 1992;45:659-666.
75. Wilson P.,Pencina M.,Jacques P.,Selhub J.,D'Agostino R.,O'Donnell C.C reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.Circulation: Cardiovascular Quality and Outcomes. 2008;1:92-97.
76. Yun A. J.,Lee P. Y.,Doux J. D.Are we eating more than we think? Illegitimate signaling and xenohormesis as participants in the pathogenesis of obesity.Medical Hypotheses. 2006;76:36-40.
77. Zachariae R.Psychoneuroimmunology: A bio-psycho-social approach to health and disease.Scandanavian Journal of Psychology. 2009;50:645-651.
78. Zumbo B. D.,Gelin M. N.,Hubley A. M. Paper session presented at the International Neuropsychological Society's 29th Annual Meeting; 2001Chicago, IL; 2001.